Abivax Files April 2024 Report on Form 6-K
Ticker: AAVXF · Form: 6-K · Filed: Apr 2, 2024 · CIK: 1956827
| Field | Detail |
|---|---|
| Company | Abivax S.A. (AAVXF) |
| Form Type | 6-K |
| Filed Date | Apr 2, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer
Related Tickers: ABVX
TL;DR
Abivax filed its monthly 6-K, confirming it's a foreign private issuer using Form 20-F.
AI Summary
Abivax S.A. filed a Form 6-K on April 2, 2024, to report its activities for the month of April 2024. The filing indicates that Abivax is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive offices are located at 7-11 boulevard Haussmann, 75009 Paris, France.
Why It Matters
This filing provides routine updates on Abivax's corporate activities as a foreign private issuer, which is important for investors tracking the company's compliance and reporting.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new material financial or operational information.
Key Players & Entities
- Abivax S.A. (company) — Registrant
- 7-11 boulevard Haussmann, 75009 Paris, France (location) — Principal executive office address
- April 2, 2024 (date) — Filing date
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report form
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
Which annual report form does Abivax S.A. file?
Abivax S.A. files its annual reports under cover of Form 20-F.
What is the filing date of this Form 6-K?
This Form 6-K was filed on April 2, 2024.
Where are Abivax S.A.'s principal executive offices located?
Abivax S.A.'s principal executive offices are located at 7-11 boulevard Haussmann, 75009 Paris, France.
Is Abivax S.A. submitting this Form 6-K in paper format?
The filing does not explicitly state if it is submitted in paper format, but it indicates Abivax is submitting the Form 6-K for the month of April 2024.
Filing Stats: 188 words · 1 min read · ~1 pages · Grade level 12 · Accepted 2024-04-02 10:24:43
Filing Documents
- f6k_040224.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 43KB
- 0001171843-24-001756.txt ( ) — 49KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Abivax SA (Registrant) Date: April 2, 2024 /s/ Marc de Garidel Marc de Garidel Chief Executive Officer